Bir sonraki

Otomatik oynatma

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

2 Görünümler • 07/14/23
Pay
gömmek
administrator
administrator
Aboneler
0

Visit http://www.ecancer.org for more

Dr Calvo (START Madrid, Madrid, Spain) talks to ecancertv at ASCO 2015 about data from a Phase 1b study of the transcriptional inhibitor PM1183 in combination with doxorubicin in second line therapy in patients with small cell lung cancer (SCLC)

Daha fazla göster
0 Yorumlar sort Göre sırala
Facebook Yorumları

Bir sonraki

Otomatik oynatma